AstraZeneca’s FluMist Influenza Vaccine FDA Approved for Self-Administration
In a landmark approval, the U.S. Food and Drug Administration (FDA) has cleared AstraZeneca’s FluMist, the only influenza vaccine that
Read moreIn a landmark approval, the U.S. Food and Drug Administration (FDA) has cleared AstraZeneca’s FluMist, the only influenza vaccine that
Read moreIn a groundbreaking leap, researchers have engineered microscopic magnetic robots that could transform the treatment of deadly brain bleeds caused
Read moreGroundbreaking Research Highlights ipRGCs as Promising Biomarkers for Neurodegenerative Diseases A Striatech .pdf Case Study OptoDrum plays a key role
Read moreGSK has announced promising headline results from its Phase III clinical trial, MATINEE, which evaluated the efficacy of Nucala (mepolizumab)
Read moreNovavax, a global leader in protein-based vaccines, has announced that its updated COVID-19 vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705), has received
Read moreNew Research Highlights the Potential of Vitamin C in Protecting Vision for Glaucoma Patients A Striatech .pdf Case Study OptoDrum,
Read morePfizer and BioNTech have announced that the U.S. Food and Drug Administration (FDA) has approved their supplemental Biologics License Application
Read moreThe unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for
Read moreThe European Commission has approved EURneffy®, the first and only needle-free adrenaline nasal spray, as an emergency treatment for allergic
Read moreSangamo Therapeutics Enters License Agreement with Genentech to Develop Genomic Medicines for Neurodegenerative Diseases Sangamo Therapeutics, Inc., a leader in
Read more